Cardiol Therapeutics Stock Forward View - Accumulation Distribution
| CRDL Stock | USD 1.04 0.02 1.96% |
Cardiol Stock outlook is based on your current time horizon. Although Cardiol Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Cardiol Therapeutics' systematic risk associated with finding meaningful patterns of Cardiol Therapeutics fundamentals over time.
As of now, the RSI of Cardiol Therapeutics' share price is approaching 46 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Cardiol Therapeutics, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.11) | EPS Estimate Current Year (0.43) | EPS Estimate Next Year (0.36) | Wall Street Target Price 7.4921 | EPS Estimate Current Quarter (0.10) |
Using Cardiol Therapeutics hype-based prediction, you can estimate the value of Cardiol Therapeutics Class from the perspective of Cardiol Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cardiol Therapeutics using Cardiol Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cardiol using crowd psychology based on the activity and movement of Cardiol Therapeutics' stock price.
Cardiol Therapeutics Implied Volatility | 2.2 |
Cardiol Therapeutics' implied volatility exposes the market's sentiment of Cardiol Therapeutics Class stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cardiol Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cardiol Therapeutics stock will not fluctuate a lot when Cardiol Therapeutics' options are near their expiration.
Cardiol Therapeutics after-hype prediction price | USD 1.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cardiol Therapeutics to cross-verify your projections. Open Interest Against 2026-03-20 Cardiol Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cardiol Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cardiol Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cardiol Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cardiol Therapeutics' open interest, investors have to compare it to Cardiol Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cardiol Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cardiol. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Cardiol Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cardiol price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cardiol using various technical indicators. When you analyze Cardiol charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 8868.96 | 20688.53 |
| Check Cardiol Therapeutics Volatility | Backtest Cardiol Therapeutics | Information Ratio |
Cardiol Therapeutics Trading Date Momentum
| On February 18 2026 Cardiol Therapeutics Class was traded for 1.04 at the closing time. The top price for the day was 1.09 and the lowest listed price was 1.02 . The trading volume for the day was 322.1 K. The trading history from February 18, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Cardiol Therapeutics to competition |
Other Forecasting Options for Cardiol Therapeutics
For every potential investor in Cardiol, whether a beginner or expert, Cardiol Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cardiol Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cardiol. Basic forecasting techniques help filter out the noise by identifying Cardiol Therapeutics' price trends.Cardiol Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardiol Therapeutics stock to make a market-neutral strategy. Peer analysis of Cardiol Therapeutics could also be used in its relative valuation, which is a method of valuing Cardiol Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cardiol Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Cardiol Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiol Therapeutics shares will generate the highest return on investment. By undertsting and applying Cardiol Therapeutics stock market strength indicators, traders can identify Cardiol Therapeutics Class entry and exit signals to maximize returns.
Cardiol Therapeutics Risk Indicators
The analysis of Cardiol Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cardiol Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cardiol stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.43 | |||
| Semi Deviation | 2.9 | |||
| Standard Deviation | 3.47 | |||
| Variance | 12.07 | |||
| Downside Variance | 12.9 | |||
| Semi Variance | 8.43 | |||
| Expected Short fall | (3.03) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cardiol Therapeutics
The number of cover stories for Cardiol Therapeutics depends on current market conditions and Cardiol Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cardiol Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cardiol Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cardiol Therapeutics Short Properties
Cardiol Therapeutics' future price predictability will typically decrease when Cardiol Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cardiol Therapeutics Class often depends not only on the future outlook of the potential Cardiol Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardiol Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 71.6 M | |
| Cash And Short Term Investments | 30.6 M |
Check out Historical Fundamental Analysis of Cardiol Therapeutics to cross-verify your projections. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiol Therapeutics. Projected growth potential of Cardiol fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cardiol Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Cardiol Therapeutics requires distinguishing between market price and book value, where the latter reflects Cardiol's accounting equity. The concept of intrinsic value - what Cardiol Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Cardiol Therapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Cardiol Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardiol Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cardiol Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.